Date and Time | Title | |
---|---|---|
May 13, 2022 8:30am - 10:10am (Eastern) | MORNING SESSION I 8:30 AM ET / 2:30 PM CEST | Welcome & Chairmen Introduction 8:45 AM ET / 2:45 PM CEST | Keynote: The VHL Tumor Suppressor Gene as a Rosetta Stone for Kidney Cancer 9:25 AM ET / 3:25 PM CEST | cGAS-like Receptors Reveal New Signals Controlling Innate Immunity 9:45 AM ET / 3:45 PM CEST | Live Q&A 9:55 AM ET / 3:55 PM CEST | Epigenetic Control of T Cell Memory and CAR T-Cell Persistence 10:22 AM ET / 4:22 PM CEST | Live Q&A | ![]() |
May 13, 2022 10:20am - 11:00am (Eastern) | MORNING BREAK | |
May 13, 2022 11:00am - 12:00pm (Eastern) | MORNING SESSION II 11:00 AM ET / 5:00 PM CEST | Immunogenic Cell Stress and Death 11:20 AM ET / 5:20 PM CEST | Live Q&A 11:30 AM ET / 5:30 PM CEST | Tumour Macrophage Heterogeneity 11:52 AM ET / 5:52 PM CEST | Live Q&A | ![]() |
May 13, 2022 12:00pm - 1:00pm (Eastern) | LUNCH BREAK | |
May 13, 2022 1:00pm - 3:05pm (Eastern) | AFTERNOON SESSION I 1:00 PM ET / 7:00 PM CEST | Microbiota-Centered Interventions for the Future of Immuno-Oncology 1:20 PM ET / 7:20 PM CEST | Live Q&A 1:30 PM ET / 7:30 PM CEST | Engineered NK Cells for Enhanced Cancer Immunotherapy 1:50 PM ET / 7:50 PM CEST | Live Q&A 2:00 PM ET / 8:00 PM CEST | GPRC5D- and Dual-Targeted CAR T-Cell Therapy 2:20 PM ET / 8:20 PM CEST | Live Q&A 2:30 PM ET / 8:30 PM CEST | Translation Control in Melanoma 3:00 PM / 9:00 PM | Live Q&A | ![]() |
May 13, 2022 3:05pm - 3:30pm (Eastern) | AFTERNOON BREAK | |
May 13, 2022 3:30pm - 5:05pm (Eastern) | AFTERNOON SESSION II 3:30 PM PM ET / 9:40 PM CEST | On the Path to Better Cancer Vaccines 3:51 PM ET / 9:51 PM CEST | Live Q&A 4:00 PM ET / 10:00 PM CEST | Immune Contexture and Immunoscore in the Era of Cancer Immunotherapy 4:20 PM ET / 10:20 PM CEST | Live Q&A 4:32 PM ET / 10:32 PM CEST | The Biology Behind PD-1 Checkpoint Blockade 4:52 PM ET / 10:52 PM CEST | Live Q&A 5:02 PM ET / 11:02 PM CEST | Conference Conclusion | ![]() |